FDA Adverse Event Injury Summary report: N

VERCISE GEVIA

MDR report key: 11499983 · Received March 17, 2021

Report

Report Number
3006630150-2021-01025
Event Type
Injury
Date Received
March 17, 2021
Date of Event
February 10, 2021
Report Date
April 20, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT, WHO IS ENROLLED IN THE VERCISE DBS REGISTRY CLINICAL TRIAL, DEVELOPED MODERATE DYSPHAGIA AND WAS ADMITTED TO THE HOSPITAL. THE PATIENT WAS TREATED WITH MEDICATION. THE DEVICE WAS REPROGRAMMED, A VIDEOFLUOROSCOPIC SWALLOW STUDY TEST AND AN L-TUBE FEEDING WAS PERFORMED. THE PATIENT IS RECOVERING AND THE EVENT IS RESOLVING. THE EVENT WAS ASSESSED AS HAVING A CAUSAL RELATIONSHIP TO THE STIMULATION, AN UNLIKELY RELATIONSHIP TO HARDWARE, AND NOT RELATED TO THE PROCEDURE.

Additional Manufacturer Narrative · 1

THE PATIENTS YEAR OF BIRTH IS (B)(6), THE EXACT DATE IS UNKNOWN. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450 , MODEL: DB-2202-45, SERIAL: (B)(4), BATCH: 5181018. PRODUCT FAMILY: DBS-LINEAR LEADS, UPN: M365DB2202450 , MODEL: DB-2202-45, SERIAL: (B)(4), BATCH: 7070157.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT DEVELOPED MODERATE DYSPHAGIA AND WAS ADMITTED TO THE HOSPITAL. THE PATIENT WAS TREATED WITH MEDICATION. THE DEVICE WAS REPROGRAMMED, A VIDEOFLUOROSCOPIC SWALLOW STUDY TEST AND AN L-TUBE FEEDING WAS PERFORMED. THE PATIENT IS RECOVERING AND THE EVENT IS RESOLVING. THE EVENT WAS ASSESSED AS HAVING A CAUSAL RELATIONSHIP TO THE STIMULATION, AN UNLIKELY RELATIONSHIP TO HARDWARE, AND NOT RELATED TO THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
398624 VERCISE GEVIA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY BOSTON SCIENTIFIC NEUROMODULATION DB-1200 740973

Patients

Seq Age Sex Outcome Treatment
1 78 YR Required Intervention